Ermengol Coma ,1 Montserrat Martinez-Marcos ,2 Eduardo Hermosilla,1,3 , et al. Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain) May 2024 . Arch Dis Child Epub doi:10.1136/ archdischild-2024-327153.